Use of &Dgr;5-androstene-3&bgr;-OL7,17-dione in the treatment of arthritis
US6794374B1 · kind B1 · utility
3Cited by
7References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 27, 2000 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Nov 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Arthritis can be treated by administering therapeutic amounts of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and metabolizable precursors thereof, such a &Dgr;5-androstene-3&bgr;-acetoxy-7,17-dione, which are readily metabolized in vivo to &Dgr;5-androstene-3&bgr;-ol-7,17-dione but are not appreciably metabolizable in vivo to androgens, estrogens or dehydroepiandrosterone. Such treatment can be prophylactic, ameliorative or curative in nature.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.